Ampio Pharmaceuticals, Inc. (AMPE)
OTCMKTS · Delayed Price · Currency is USD
0.0027
-0.0002 (-6.90%)
Aug 15, 2025, 12:08 PM EDT
Ampio Pharmaceuticals Company Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States.
The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.
Ampio Pharmaceuticals, Inc.
| Country | United States |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Michael Martino |
Contact Details
Address: 9800 Mount Pyramid Court Englewood, Delaware 80112 United States | |
| Phone | 720 437 6500 |
| Website | ampiopharma.com |
Stock Details
| Ticker Symbol | AMPE |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | US03209T1097 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Michael A. Martino | Chief Executive Officer, Chief Financial Officer, General Secretary and Director |
| Dr. David Bar-Or M.D. | Founder and Chairman of Scientific Advisory Board |
| April Ramirez | Clinical Trial Manager |